Rubric Capital Management LP 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-17 4:32 pm Purchase | 2024-06-17 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 108,486,735 14.200% | 8,771,750 (+8.80%) | Filing |
| 2024-04-16 2:58 pm Purchase | 2024-04-15 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 99,714,985 14.220% | 10,100 (+0.01%) | Filing |
| 2023-11-20 08:45 am Purchase | 2023-11-16 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 99,704,885 14.220% | 2,378,330 (+2.44%) | Filing |
| 2023-11-15 07:56 am Purchase | 2023-11-13 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 97,326,555 13.880% | 7,200 (+0.01%) | Filing |
| 2023-11-13 07:31 am Purchase | 2023-11-09 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 97,319,355 13.880% | 1,758,195 (+1.84%) | Filing |
| 2023-11-08 07:06 am Purchase | 2023-11-06 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 95,561,160 13.630% | 2,188,575 (+2.34%) | Filing |
| 2023-11-06 07:30 am Purchase | 2023-11-03 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 93,372,585 13.320% | 1,081,380 (+1.17%) | Filing |
| 2023-11-02 07:30 am Purchase | 2023-10-31 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 92,291,205 13.250% | 92,130 (+0.10%) | Filing |
| 2023-10-30 6:02 pm Purchase | 2023-10-27 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 92,199,075 13.150% | 2,168,475 (+2.41%) | Filing |
| 2023-06-16 08:00 am Purchase | 2023-06-14 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 90,030,600 14.410% | 6,250,000 (+7.46%) | Filing |
| 2022-10-28 1:17 pm Unchanged | 2022-10-28 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 83,780,600 13.410% | 0 (Unchanged) | Filing |
| 2022-09-23 4:18 pm Unchanged | 2022-09-15 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 83,780,600 13.410% | 0 (Unchanged) | Filing |
| 2022-08-23 6:31 pm Purchase | 2022-08-19 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 83,780,600 14.320% | 1,507,790 (+1.83%) | Filing |
| 2022-06-14 10:21 am Purchase | 2022-06-13 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 82,272,810 14.070% | 5,480,185 (+7.14%) | Filing |
| 2022-06-09 08:00 am Purchase | 2022-06-09 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 76,792,625 13.129% | 1,792,625 (+2.39%) | Filing |
| 2022-05-26 5:29 pm Purchase | 2022-05-26 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 75,000,000 12.820% | 427,765 (+0.57%) | Filing |
| 2022-02-14 08:50 am Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 74,572,235 13.700% | 18,072,235 (+31.99%) | Filing |
| 2021-12-02 2:31 pm Purchase | 2021-09-30 | 13G | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 56,500,000 10.380% | 56,500,000 (New Position) | Filing |